APA (7 ম সংস্করণ) উদ্ধৃতি

Murphy, F., Church, D., Medley, L., Davies, J., Breen, D., Clelland, C., . . . Talbot, D. (2011). PHASE II TRIAL OF ERLOTINIB AS FIRST-LINE THERAPY IN NON-SMALL CELL LUNG CANCER OVER-EXPRESSING EGFR.

শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতি

Murphy, F., et al. PHASE II TRIAL OF ERLOTINIB AS FIRST-LINE THERAPY IN NON-SMALL CELL LUNG CANCER OVER-EXPRESSING EGFR. 2011.

M.L.A (9 ম সংস্করণ) উদ্ধৃতি

Murphy, F., et al. PHASE II TRIAL OF ERLOTINIB AS FIRST-LINE THERAPY IN NON-SMALL CELL LUNG CANCER OVER-EXPRESSING EGFR. 2011.